Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build Lithuania flag

Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions

CodeSystem: Prostate questionnaire answer options (illustrative) (Experimental)

Official URL: https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options Version: 0.0.1
Computable Name: ProstateQuestionnaireOptions

Illustrative codes for Questionnaire answer options for prostate ESPBI-style forms in this IG. Register or replace with national coded values in production.

This Code system is referenced in the definition of the following value sets:

  • This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Language: en

This case-sensitive code system https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options defines the following codes:

CodeDisplay
specimen-satisfactory Specimen satisfactory for evaluation
specimen-limited Specimen satisfactory but limited
specimen-insufficient Insufficient tissue for diagnosis
treatment-unknown Treatment effect unknown
treatment-unidentifiable Treatment effect unidentifiable
treatment-radiotherapy Observed radiotherapy effect
treatment-hormone Observed hormone therapy effect
treatment-other Observed other therapy effect
hist-acinar Acinar adenocarcinoma (conventional)
hist-acinar-signet-ring Acinar adenocarcinoma, signet-ring cell-like
hist-acinar-pleomorphic Acinar adenocarcinoma, pleomorphic giant cell
hist-acinar-sarcomatoid Acinar adenocarcinoma, sarcomatoid
hist-acinar-pin-like Acinar adenocarcinoma, PIN-like
hist-idc-isolated Isolated intraductal carcinoma
hist-ductal Ductal adenocarcinoma
hist-adenosquamous Adenosquamous carcinoma
hist-squamous Squamous cell carcinoma
hist-basal-cell Basal cell (adenoid cystic) carcinoma
hist-neuro-adeno Adenocarcinoma with neuroendocrine differentiation
hist-neuro-well-diff Well-differentiated neuroendocrine tumor
hist-neuro-small-cell Small cell neuroendocrine carcinoma
hist-neuro-large-cell Large cell neuroendocrine carcinoma
hist-unassessable Carcinoma, type unassessable
hist-other Other histological type (see comment)
isup-gg1 ISUP Grade Group 1 (Gleason 3+3)
isup-gg2 ISUP Grade Group 2 (Gleason 3+4)
isup-gg3 ISUP Grade Group 3 (Gleason 4+3)
isup-gg4 ISUP Grade Group 4 (Gleason 4+4 or equivalent)
isup-gg5 ISUP Grade Group 5 (Gleason 4+5 / 5+4 / 5+5)
idc-absent Intraductal carcinoma not identified
idc-present Intraductal carcinoma identifiable
cribriform-na Cribriform not applicable
cribriform-unknown Cribriform undefined
cribriform-present Cribriform identifiable
dre-not-done DRE not performed
dre-normal DRE normal
dre-suspicious DRE suspicious
referral-screening Referral for screening
referral-elevated-psa Referral for elevated PSA
referral-other Other referral reason
ynk-yes Yes
ynk-no No
ynk-unknown Unknown
pirads-cat-1-2 PI-RADS 1–2
pirads-cat-3 PI-RADS 3
pirads-cat-4 PI-RADS 4
pirads-cat-5 PI-RADS 5
pattern4-pct-na Pattern 4 %: not applicable
pattern4-pct-lte5 Pattern 4 %: ≤5%
pattern4-pct-6-10 Pattern 4 %: 6–10%
pattern4-pct-gt40 Pattern 4 %: >40%
tumor-pct-lt1 Tumour % in biopsy: <1%
tumor-pct-1-5 Tumour % in biopsy: 1–5%
tumor-pct-gt90 Tumour % in biopsy: >90%
tumor-pct-uneval Tumour %: cannot be evaluated
periprostatic-unknown Periprostatic fat invasion: unidentifiable
periprostatic-absent Periprostatic fat invasion: not identified
periprostatic-present Periprostatic fat invasion: present
biopsy-initial Initial biopsy
biopsy-repeat Repeat biopsy
fixative-buffered-formalin 10% buffered formalin
fixative-unfixed Unfixed (no fixative)
dx-n40-gph N40 Glandular prostatic hyperplasia
dx-c61 C61 Malignant neoplasm of prostate
ct-1c cT1c
ct-2 cT2
ct-3a cT3a
ct-3b cT3b
op-transperineal Transperineal biopsy
op-transrectal Transrectal biopsy
proc-systematic Systematic biopsy
proc-adaptive Adaptive biopsy
proc-systematic-targeted Systematic + targeted biopsy
proc-applicative-perifocal Applicative + perifocal biopsy
perineural-present Perineural invasion present
perineural-absent Perineural invasion not identified
perineural-ambiguous Perineural invasion ambiguous
perineural-uneval Perineural invasion cannot be evaluated
lymphovascular-present Lymphovascular invasion identifiable
lymphovascular-absent Lymphovascular invasion unidentifiable / not available
lymphovascular-ambiguous Lymphovascular invasion ambiguous
lymphovascular-uneval Lymphovascular invasion cannot be evaluated

Description of the above table(s).